Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tiabendazole Hydrochloride
2. 945-65-3
3. 19525-20-3
4. N3b9akc0t9
5. Benzimidazole, 2-(4-thiazolyl)-, Monohydrochloride
6. Nsc-81948
7. 4-(1h-benzimidazol-2-yl)-1,3-thiazole;hydrochloride
8. 1h-benzimidazole, 2-(4-thiazolyl)-, Hydrochloride (1:1)
9. Mk 360 Hydrochloride
10. Einecs 243-132-6
11. Unii-n3b9akc0t9
12. 2-(4-thiazolyl)benzimidazole Hydrochloride
13. Benzimidazole, 2-(4-thiazolyl)-, Hydrochloride
14. Mintezol Hydrochloride
15. Schembl2314460
16. Dtxsid10941293
17. Nsc81948
18. Nsc 81948
19. 2-(4-thiazolyl)benzimidazole Monohydrochloride
20. 2-(1,3-thiazol-4-yl)-1h-benzimidazole Hydrochloride
21. Q27284505
22. 2-(1,3-thiazol-4-yl)-1h-benzo[d]imidazole Hydrochloride
23. 2-(1,3-thiazol-4-yl)-1h-benzimidazole--hydrogen Chloride (1/1)
| Molecular Weight | 237.71 g/mol |
|---|---|
| Molecular Formula | C10H8ClN3S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 237.0127461 g/mol |
| Monoisotopic Mass | 237.0127461 g/mol |
| Topological Polar Surface Area | 69.8 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 212 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Tiabendazole Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiabendazole Hydrochloride, including repackagers and relabelers. The FDA regulates Tiabendazole Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiabendazole Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tiabendazole Hydrochloride supplier is an individual or a company that provides Tiabendazole Hydrochloride active pharmaceutical ingredient (API) or Tiabendazole Hydrochloride finished formulations upon request. The Tiabendazole Hydrochloride suppliers may include Tiabendazole Hydrochloride API manufacturers, exporters, distributors and traders.
Tiabendazole Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiabendazole Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiabendazole Hydrochloride GMP manufacturer or Tiabendazole Hydrochloride GMP API supplier for your needs.
A Tiabendazole Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Tiabendazole Hydrochloride's compliance with Tiabendazole Hydrochloride specifications and serves as a tool for batch-level quality control.
Tiabendazole Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Tiabendazole Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiabendazole Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiabendazole Hydrochloride EP), Tiabendazole Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiabendazole Hydrochloride USP).
LOOKING FOR A SUPPLIER?
